Title : Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?

Pub. Date : 2015 Dec

PMID : 26798590






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine? alectinib ret proto-oncogene Homo sapiens
2 Alectinib, a second generation ALK inhibitor, was shown to block growth of cells with RET fusions. alectinib ret proto-oncogene Homo sapiens
3 Thus alectinib should be further evaluated within clinical trials in patients with RET fusion-positive adenocarcinomas of the lung. alectinib ret proto-oncogene Homo sapiens